7Baggers

We provide you with 20 years of free, institutional-grade data for HOWL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HOWL. Explore the full financial landscape of HOWL stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
Login to see more insider transactions
The information provided in this report about HOWL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Werewolf Therapeutics Inc
(NASDAQ:HOWL) 

HOWL stock logo

Werewolf Therapeutics is a highly innovative company striving to redefine the cancer treatment landscape with potential best-in-class therapies.

Founded: 2017
CEO: Dan Hicklin  
Sector:
Industry:

Share this website to your friends